Infinity Pharmaceuticals | INFI - Ebit


Infinity Pharmaceuticals reported $-10.12M in EBIT for its fiscal quarter ending in June of 2023.





Ebit Change Date
AbbVie USD 5.81B 4.36B Dec/2025
Alterity Therapeutics Limited AUD -7.77M 2.99M Jun/2023
Amgen USD 3.96B 464M Dec/2025
AstraZeneca USD 2.97B 4.48B Dec/2025
Bristol-Myers Squibb USD 3.47B 567M Dec/2025
Cipla INR 9.77B 6.21B Dec/2025
Clal Biotechnology ILS -5.44M 3.76M Dec/2022
Compugen USD -7.89M 536K Sep/2025
CSL USD 2.75B 1.35B Dec/2024
Eisai JPY 20.03B 6.36B Dec/2025
Eli Lilly USD 8.99B 1.57B Dec/2025
Gilead Sciences USD 2.96B 551M Dec/2025
GlaxoSmithKline GBP 1.44B 1.35B Dec/2025
Grifols EUR 411.56M 15.51M Sep/2025
Incyte USD 383.88M 47.44M Dec/2025
Infinity Pharmaceuticals USD -10.12M 1.39M Jun/2023
Ionis Pharmaceuticals USD -160.18M 304.96M Sep/2025
J&J USD 5.11B 2.3B Dec/2025
Novartis USD -9.19B 13.87B Jun/2025
Pfizer USD 4.65B 71M Dec/2025
Roche Holding CHF 9.56B 2.1B Dec/2025
TG Therapeutics USD 29.36M 5.48M Sep/2025